Leguisan, Gorita A.
HRN: 08-14-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/13/2023
07/19/2023
IV
300 Mg
Q6H
Cellulitis, Left Thigh
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes